GlucoTrack logo

GlucoTrackNASDAQ: GCTK

Profile

Sector:

Healthcare

Country:

United States

IPO:

25 April 2013

Next earnings report:

15 May 2025

Last dividends:

N/A

Next dividends:

N/A
$2.09 M
-97%vs. 3y high
5%vs. sector
-vs. 3y high
-vs. sector
-100%vs. 3y high
12%vs. sector
-vs. 3y high
-vs. sector

Price

after hours | Thu, 21 Nov 2024 00:08:46 GMT
$0.25$0.00(0.00%)

Dividend

No data over the past 3 years
No data over the past 3 years

Analysts recommendations

Institutional Ownership

GCTK Latest News

Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt
globenewswire.com14 November 2024 Sentiment: POSITIVE

Rutherford, NJ., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced the closing of a “best efforts” public offering of 2,437,340 shares of common stock and 4,756,900 pre-funded warrants, with each share of common stock and each pre-funded warrant accompanied by (i) a series A common warrant to purchase one (1) share of common stock at an exercise price of $1.81 per share and (ii) a series B common warrant to purchase one (1) share of common stock at an exercise price of $1.81 per share. The combined offering price of each share of common stock together with the accompanying series A and series B common warrants is $1.39, and the combined offering price of each pre-funded warrant together with the accompanying series A and series B common warrants is $1.389. The gross proceeds of the public offering were approximately $10 million before deducting placement agent fees and offering expenses.

GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING
globenewswire.com01 October 2024 Sentiment: POSITIVE

Updated preclinical data for the continuous blood glucose monitor to be presented at major diabetes technology conference

Glucotrack's Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference
globenewswire.com15 August 2024 Sentiment: POSITIVE

Glucotrack ADCES poster highlights over 50% of surveyed diabetes patients are open to new Continuous Blood Glucose Monitor concept

GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE
globenewswire.com10 June 2024 Sentiment: POSITIVE

Rutherford, NJ, June 10, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it will participate in the Sidoti Small Cap Investor Conference.

Why Is GlucoTrack (GCTK) Stock Down 36% Today?
InvestorPlace13 April 2023 Sentiment: NEGATIVE

GlucoTrack (NASDAQ: GCTK ) stock is falling on Thursday after the medical device company revealed plans for a proposed public stock offering. According to a news release from the company, it's planning for a firm commitment underwritten public offering.

What type of business is GlucoTrack?

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

What sector is GlucoTrack in?

GlucoTrack is in the Healthcare sector

What industry is GlucoTrack in?

GlucoTrack is in the Medical Instruments & Supplies industry

What country is GlucoTrack from?

GlucoTrack is headquartered in United States

When did GlucoTrack go public?

GlucoTrack initial public offering (IPO) was on 25 April 2013

What is GlucoTrack website?

https://glucotrack.com

Is GlucoTrack in the S&P 500?

No, GlucoTrack is not included in the S&P 500 index

Is GlucoTrack in the NASDAQ 100?

No, GlucoTrack is not included in the NASDAQ 100 index

Is GlucoTrack in the Dow Jones?

No, GlucoTrack is not included in the Dow Jones index

When was GlucoTrack the previous earnings report?

No data

When does GlucoTrack earnings report?

The next expected earnings date for GlucoTrack is 15 May 2025